Press Releases
-
Expert Speaker Lineup Revealed for Award Winning RBQM Event
Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
Jul 31, 2023
-
The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change
The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.
Jul 31, 2023
-
Adaptive Research Appoints Kristin Andruska, MD, PhD as Senior Medical Director and Clinical Neuroscience & Scientific Research Director
Adaptive Research, an organization committed to democratizing clinical trials by providing full-service support to trial investigators in community settings, is pleased to announce Kristin Andruska, MD, PhD has been appointed Senior Medical Director of Clinical Neuroscience and Scientific Research Director.
Jul 24, 2023
-
TransCure bioServices expands reach into APAC with Preclina Inc partnership
TransCure bioServices has expanded its reach in the APAC region by signing a strategic partnership with leading South Korean preclinical research company Preclina Inc.
Jul 24, 2023
-
BioIVT to Discuss its Pivotal Role in Liquid Biopsy Research at the AACC Annual Scientific Meeting and Clinical Lab Expo
BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.
Jul 20, 2023
-
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
TVM Capital Life Science together withTillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.
Jul 19, 2023
-
PrecisionLife Identifies First Detailed Genetic Risk Factors for Long COVID and Common Mechanisms with ME/CFS and other Complex Diseases
PrecisionLife has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases.
Jul 17, 2023
-
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers Acquisition expands customers' ability to accelerate their advanced bioconjugate
Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications
Jul 16, 2023
-
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein Manufacture
Lonza has launched the TheraPRO® CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines.
Jul 16, 2023
-
AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer
AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.
Jul 17, 2023
-
BioIVT Acquires PrecisionMed, a Leading Global Provider of Biospecimens for Neurology and Oncology Research
PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research.
Jul 17, 2023
-
Upperton completes build of new £15m development and GMP manufacturing facility
-
Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities
Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research.
Jul 12, 2023
-
Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements
Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.
Jul 10, 2023
-
Phastar's B Corp™ certification affirms its status as a 'force for good' organization
Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.
Jul 10, 2023
-
Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production
Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Combining the specific expertise of each partner, H&T Presspart will manufacture Kindeva Drug Delivery’s dose counters under license for Chiesi Group for their pressurized metered-dose inhaler (pMDI) portfolio.
Jul 10, 2023
-
Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients
Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative, designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. The service uses data-driven intelligence to help customers identify and engage with the right partner, whether it be for licencing, in-licensing, funding, distribution, or any other business need.
Jul 5, 2023
-
VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research
VitaDAO has announced the launch of the VITA-FAST tokens.
Jul 2, 2023
-
LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
-
ENPICOM secures extended financing from BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital
ENPICOM has successfully secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital.
Jun 28, 2023